Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

Use of Tumor Markers in Liver, Bladder, Cervical and Gastric Cancers
  • Copyright:2010
  • Pages:0

Price: $45.00

Member Price: $45.00

Rating: Member Average

These guidelines are intended to encourage more appropriate use of tumor marker tests by primary care physicians, hospital physicians and surgeons, specialist oncologists, and other health professionals. Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most common cause of cancer-related death, with 500,000 new cases diagnosed yearly. The rationale behind screening for HCC by regular liver ultrasound and tumor marker measurement in high-risk but asymptomatic groups is the early identification of tumors when they are still curable.